The Advisory Committee on Immunization Practices (ACIP) recommendations have been updated for the meningococcal serogroup B MenB-4C vaccine (Bexsero), in accordance with the updated U.S. Food and Drug Administration label. The updated recommendations have been published in the Dec. 12 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
from Medical Xpress - latest medical and health news stories https://ift.tt/c1UGezO
